Perspectives for repurposing drugs for the coronavirus disease 2019

The newly emerged 2019 novel coronavirus (CoV), named as severe acute respiratory syndrome CoV-2 (SARS-CoV-2), like SARS-CoV (now, SARS-CoV-1) and Middle East respiratory syndrome CoV (MERS-CoV), has been associated with high infection rates with over 36,405 deaths. In the absence of approved market...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherian, Sarah S., Agrawal, Megha, Basu, Atanu, Abraham, Priya, Gangakhedkar, Raman R., Bhargava, Balram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357399/
https://www.ncbi.nlm.nih.gov/pubmed/32317408
http://dx.doi.org/10.4103/ijmr.IJMR_585_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357399/
https://www.ncbi.nlm.nih.gov/pubmed/32317408
http://dx.doi.org/10.4103/ijmr.IJMR_585_20

Ejemplares similares